Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

CollPlant Biotechnologies (CLGN) EPS (Basic) (2018 - 2025)

Historic EPS (Basic) for CollPlant Biotechnologies (CLGN) over the last 8 years, with Q3 2025 value amounting to -$0.27.

  • CollPlant Biotechnologies' EPS (Basic) fell 17105.26% to -$0.27 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.2, marking a year-over-year decrease of 11030.93%. This contributed to the annual value of -$1.44 for FY2024, which is 33251.86% down from last year.
  • As of Q3 2025, CollPlant Biotechnologies' EPS (Basic) stood at -$0.27, which was down 17105.26% from $0.28 recorded in Q2 2025.
  • In the past 5 years, CollPlant Biotechnologies' EPS (Basic) registered a high of $2.67 during Q4 2022, and its lowest value of -$0.4 during Q3 2022.
  • Over the past 5 years, CollPlant Biotechnologies' median EPS (Basic) value was $0.36 (recorded in 2022), while the average stood at $0.36.
  • As far as peak fluctuations go, CollPlant Biotechnologies' EPS (Basic) plummeted by 39000.0% in 2021, and later surged by 78461.54% in 2022.
  • CollPlant Biotechnologies' EPS (Basic) (Quarter) stood at -$0.39 in 2021, then skyrocketed by 784.62% to $2.67 in 2022, then crashed by 69.29% to $0.82 in 2023, then crashed by 142.31% to -$0.35 in 2024, then grew by 22.18% to -$0.27 in 2025.
  • Its EPS (Basic) was -$0.27 in Q3 2025, compared to $0.28 in Q2 2025 and $0.13 in Q1 2025.